pillbase.ru

Polivy

Active substance: Polatuzumab vedotin

polatuzumab vedotin

Centralised EU authorisationActive

Marketing holder: Roche Registration GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • ПОЛАЙВИ®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 140 мг, 140 мг (original in Russian, GRLS)
    ЛП-006599
    Ф. Хоффманн-Ля Рош Лтд.
  • Полайви®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 140 мг, 140 мг (original in Russian, GRLS)
    ЛП-№(002088)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
US 2
  • POLIVY
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · POLATUZUMAB VEDOTIN 30 mg/1.88mL
    50242-103
    Genentech, Inc.
  • POLIVY
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · POLATUZUMAB VEDOTIN 140 mg/7.52mL
    50242-105
    Genentech, Inc.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-45d7-710e-abd6-20d6d91cd89b,01a120c5-e510-7161-b0e7-1d7b2b67a96e;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-6003-75d2-9f62-6b39d3dd8627,01a12098-bc1b-7186-b41a-dbd3d2a914d3;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004870
Registration status
Active
ATC code
L01FX14
Sources
  • product · EMA · EMEA/H/C/004870 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004870 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004870 · Verified 2026-10-09